Rasagiline Mesylate
Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease. (In Vitro) :Rasagiline (0.25 nM; 96 hours) significantly increases the proliferation rates of SH-SY5Y and 1242-MG upon Dexamethasone (10 μM) treatment. (In Vivo) :Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Motor behavioural tests show improvements in motor deficits associated with 2.5 mg/kg Rasagiline therapy.
Product Specifications
CAS Number
161735-79-1
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Soluble in water
Smiles
CS (=O) (=O) O.C#CCN[C@@H]1CCC2=CC=CC=C12
Molecular Formula
C13H17NO3S
Molecular Weight
267.34
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2524-500 1x 500 µL
SMAD4 (Pancreatic Adenocarcinoma Marker) (SMAD4/2524), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TP321735 20 µg
NHP2L1 (SNU13) (NM_001003796) Human Recombinant Protein
Sign In for Pricing
View Details 